We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




7T MRI Used in Brain Disorder Research Collaboration

By LabMedica International staff writers
Posted on 16 Nov 2011
A 7-T magnetic resonance imaging (MRI) investigational scanner will be used to support academic research on functional brain mapping, high-resolution anatomic imaging of the brain, spectroscopy of the brain, assessment of tumor response to treatment, and cardiovascular imaging.

GE Healthcare (Chalfont St. More...
Giles, UK) and University of Iowa Health Care (Iowa City, USA) announced that they would collaborate on ultra-high-field MRI to study brain disorders. The purchase of the GE equipment for research use will be funded with a National Institutes of Health (NIH) high-end instrumentation grant awarded to Vincent Magnotta, PhD, in the department of radiology at University of Iowa Hospitals and Clinics in Iowa City (IA, USA).

The GE 7 T MR imaging scanner will provide ultra-high-field whole body scanning capabilities for MRI research. It will be housed in the University’s new Pappajohn Biomedical Discovery Institute, currently under construction. It is being acquired by the University of Iowa to support the research efforts of 33 funded US National Institutes of Health (NIH; Bethesda, MD, USA) investigators from five colleges (medicine, engineering, public health, liberal arts and sciences, and business) with more than 40 NIH grants. This group of researchers from University of Iowa has a wide range of interests including functional brain mapping, high-resolution anatomical imaging of the brain, spectroscopy of the brain, evaluation of tumor response to treatment, and cardiovascular imaging.

“We are honored and delighted to work with the University of Iowa to provide ultra-high-field strength MR imaging capabilities to help study patients with a variety of brain disorders,” said Jacques Coumans PhD, general manager of GE Healthcare’s MRI business. “Our 7 T MRI research system has the abilities to provide increased image resolution and sensitivity to help accelerate translational research. This collaboration is an excellent representation of how academic-industrial partnerships can help define new directions with the goal of facilitating more immediate health improvements and better outcomes.”

Three medical device vendors participated in a competitive proposal process for the research scanner purchase.

Related Links:
GE Healthcare
University of Iowa Health Care



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.